Key result
Blocking myosin VI enhances beta cell insulin release by altering GIPR endocytosis and signaling.
Why the study?
While GPCR endocytosis is traditionally associated with beta-arrestin, GIPR internalization is only modestly dependent on this pathway, leaving its endocytic mechanisms incompletely understood.
The study reveals that β-arrestin and myosin VI cooperatively control GIPR internalization and signaling, and blocking myosin VI enhances insulin release in pancreatic beta cells.
Glucose-dependent insulinotropic peptide receptor (GIPR) stimulates insulin release and regulates metabolic homeostasis. GIPR function is shaped by spatiotemporal trafficking of this G protein-coupled receptor (GPCR). While GPCR endocytosis is traditionally associated with β-arrestin, GIPR internalization is only modestly dependent on this pathway. In this study, we demonstrate that GIPR engages a cytoskeletal motor, myosin VI to drive receptor endocytosis. GIPR engages the adaptor-motor complex through a PDZ-binding motif (PBM) at its C-ail. Interestingly, β-arrestin binding to phosphorylated residues upstream of the PBM enhance myosin VI recruitment and activation. GIPR internalization is dependent on both receptor phosphorylation and the PBM site to recruit β-arrestin and myosin VI, respectively. Cooperative engagement of β-arrestin and myosin VI results in desensitization of GIP-stimulated cAMP signaling while activating pERK1/2 from endosomal compartments. Blocking myosin VI activity enhances insulin release in pancreatic beta cells, demonstrating a novel role for this pathway in regulating the physiological effects of GIPR. Our findings highlight the direct convergence of two independent trafficking pathways at the level of the receptor C-tail, with implications for the nuanced regulation of individual GPCRs through the differential engagement of β-arrestin and myosin VI.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question. Blocking myosin VI activity was evaluated on GIPR internalization, signaling dynamics, and insulin release. Blocking myosin VI activity enhances insulin release in pancreatic beta cells, demonstrating its cooperative role with β-arrestin in GIPR endocytosis and signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: